FDA.reportPublic FDA data

0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe

RxCUI
2583641
RxNorm name
0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe
Display name
0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe
Full name
0.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled Syringe
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:23

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125740TicovacTick-Borne Encephalitis Vaccine351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
da102644-62a9-41c2-8a91-6fc19a03e6f10.25 ML tick-borne encephalitis purified antigen 0.0048 MG/ML Prefilled SyringeSCD7These highlights do not include all the information needed to use TICOVAC safely and effectively. See full prescribing information for TICOVAC. TICOVAC (Tick-Borne Encephalitis Vaccine), Suspension for intramuscular injection Initial U.S. Approval: 202120260317
da102644-62a9-41c2-8a91-6fc19a03e6f1ick-borne encephalitis purified antigen 1.2 MCG per 0.25 ML Prefilled SyringeSY7These highlights do not include all the information needed to use TICOVAC safely and effectively. See full prescribing information for TICOVAC. TICOVAC (Tick-Borne Encephalitis Vaccine), Suspension for intramuscular injection Initial U.S. Approval: 202120260317
da102644-62a9-41c2-8a91-6fc19a03e6f1tick-borne encephalitis purified antigen 1.2 MCG in 0.25 ML Prefilled SyringePSN7These highlights do not include all the information needed to use TICOVAC safely and effectively. See full prescribing information for TICOVAC. TICOVAC (Tick-Borne Encephalitis Vaccine), Suspension for intramuscular injection Initial U.S. Approval: 202120260317